EMPLOYEE STOCK BENEFIT PLANS (Details 2) (USD $) In Thousands, unless otherwise specified	3 Months Ended		9 Months Ended		1 Months Ended	3 Months Ended	9 Months Ended	3 Months Ended		9 Months Ended		3 Months Ended		9 Months Ended		1 Months Ended	3 Months Ended	9 Months Ended	3 Months Ended		9 Months Ended		1 Months Ended	3 Months Ended	9 Months Ended
	Sep. 30, 2013	Sep. 30, 2012	Sep. 30, 2013	Sep. 30, 2012	Sep. 30, 2013 Trius Therapeutics, Inc.	Sep. 30, 2013 Trius Therapeutics, Inc.	Sep. 30, 2013 Trius Therapeutics, Inc.	Sep. 30, 2013 Cost of product revenues	Sep. 30, 2012 Cost of product revenues	Sep. 30, 2013 Cost of product revenues	Sep. 30, 2012 Cost of product revenues	Sep. 30, 2013 Research and development	Sep. 30, 2012 Research and development	Sep. 30, 2013 Research and development	Sep. 30, 2012 Research and development	Sep. 30, 2013 Research and development Trius Therapeutics, Inc.	Sep. 30, 2013 Research and development Trius Therapeutics, Inc.	Sep. 30, 2013 Research and development Trius Therapeutics, Inc.	Sep. 30, 2013 Selling, general and administrative	Sep. 30, 2012 Selling, general and administrative	Sep. 30, 2013 Selling, general and administrative	Sep. 30, 2012 Selling, general and administrative	Sep. 30, 2013 Selling, general and administrative Trius Therapeutics, Inc.	Sep. 30, 2013 Selling, general and administrative Trius Therapeutics, Inc.	Sep. 30, 2013 Selling, general and administrative Trius Therapeutics, Inc.
Summary of Stock-based Compensation Expense
Total stock-based compensation	$ 7,965	$ 6,752	$ 24,104	$ 19,244	$ 24,000	$ 24,000	$ 24,000	$ 120	$ 133	$ 374	$ 305	$ 2,816	$ 2,371	$ 8,583	$ 6,724	$ 12,400	$ 12,400	$ 12,400	$ 5,029	$ 4,248	$ 15,147	$ 12,215	$ 11,600	$ 11,600	$ 11,600
Income tax effect	(2,993)	(2,302)	(9,058)	(6,770)
After-tax effect of stock-based compensation expense	$ 4,972	$ 4,450	$ 15,046	$ 12,474